Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Thiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple Sclerosis.
Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1000 Genomes Project.
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
Enhanced patient support services improve patient persistence with multiple sclerosis treatment.
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems.
Protein-based classifier to predict conversion from clinically isolated syndrome to multiple sclerosis.
Relation of Demographics and Reported Symptoms and Medication Use in Persons with Multiple Sclerosis.
Autophagic myelin destruction by schwann cells during wallerian degeneration and segmental demyelination.
Plasmablast in the pathology of multiple sclerosis.
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.
Immunopathology of multiple sclerosis.
A specific vaccine to protect patients with multiple sclerosis from herpes zoster.
The myelin proteolipid plasmolipin, forms oligomers and induces liquid ordered membranes in the Golgi apparatus.
Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis.
Neuromyelitis optica.
The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.
Photobiomodulation Induced by 670 nm Light Ameliorates MOG35-55 Induced EAE in Female C57BL/6 Mice: A Role for Remediation of Nitrosative Stress.
Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.
Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: Diagnostic considerations.
Frequency analysis approach to study balance control in individuals with multiple sclerosis.
Pages
« first
‹ previous
…
481
482
483
484
485
486
487
488
489
…
next ›
last »